NADPH oxidase 1, a novel molecular source of ROS in hippocampal neuronal death in vascular dementia

Antioxidants and Redox Signaling

Volumn 21, Issue 4, 2014, Pages 533-550

  Choi, Dong Hee ^a,b   Lee, Kyoung Hee ^a   Kim, Ji Hye ^a   Seo, Ju Ha ^a   Kim, Hahn Young ^a   Shin, Chan Young ^a   Han, Jung Soo ^a   Han, Seol Heui ^a   Kim, Yoon Seong ^c   Lee, Jongmin ^a,b  

^a Konkuk University   (South Korea)

^b Konkuk University School of Medicine   (South Korea)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOCYNIN; MESSENGER RNA; RAC1 PROTEIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 1; SUPEROXIDE; ACETOPHENONE DERIVATIVE; OXIDOREDUCTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DNA DAMAGE; ENZYME INHIBITION; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL NEURONAL CULTURE; HIPPOCAMPUS; MALE; MEMORY DISORDER; MULTIINFARCT DEMENTIA; NERVE CELL DEGENERATION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; CELL DEATH; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION; GENETICS; MEMORY; METABOLISM; OXIDATION REDUCTION REACTION; PATHOLOGY; PYRAMIDAL NERVE CELL; RNA INTERFERENCE;

ACETOPHENONES; ANIMALS; CELL DEATH; DEMENTIA, VASCULAR; DISEASE MODELS, ANIMAL; DNA DAMAGE; GENE EXPRESSION; HIPPOCAMPUS; MALE; MEMORY; NADH, NADPH OXIDOREDUCTASES; OXIDATION-REDUCTION; OXIDATIVE STRESS; PYRAMIDAL CELLS; RAC1 GTP-BINDING PROTEIN; RATS; REACTIVE OXYGEN SPECIES; RNA INTERFERENCE; SUPEROXIDES;

EID: 84903935281     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.5129     Document Type: Article

References (77)

1. Abramov AY, Jacobson J, Wientjes F, Hothersall J, Canevari L, and Duchen MR. Expression and modulation of an NADPH oxidase in mammalian astrocytes. J Neurosci 25: 9176-9184, 2005.
2. Aggarwal NT and Decarli C. Vascular dementia: emerging trends. Semin Neurol 27: 66-77, 2007.
3. Aliev G, Smith MA, Obrenovich ME, de la Torre JC, and Perry G. Role of vascular hypoperfusion-induced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease. Neurotox Res 5: 491-504, 2003.
4. Barone E, Di Domenico F, Cenini G, Sultana R, Cini C, Preziosi P, Perluigi M, Mancuso C, and Butterfield DA. Biliverdin reductase-a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment. Biochim Biophys Acta 1812: 480-487, 2011.
5. Barone E, Di Domenico F, Cenini G, Sultana R, Coccia R, Preziosi P, Perluigi M, Mancuso C, and Butterfield DA. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment. J Alzheimers Dis 25: 623-633, 2011.
6. Barone E, Di Domenico F, Sultana R, Coccia R, Mancuso C, Perluigi M, and Butterfield DA. Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment. Free Radic Biol Med 52: 2292-2301, 2012.
7. Bedard K and Krause KH. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 87: 245-313, 2007.
8. Bennett S, Grant MM, and Aldred S. Oxidative stress in vascular dementia and Alzheimer's disease: A common pathology. J Alzheimers Dis 17: 245-257, 2009.
9. Block ML. NADPH oxidase as a therapeutic target in Alzheimer's disease. BMC Neurosci 9 Suppl 2: S8, 2008.
10. Bokoch GM and Diebold BA. Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 100: 2692-2696, 2002.
11. Brennan AM,Suh SW, Won SJ, Narasimhan P, Kauppinen TM, Lee H, Edling Y, Chan PH, and Swanson RA. NADPH oxidase is the primary source of superoxide induced byNMDAreceptor activation. Natu Neurosci 12: 857-863, 2009.
12. Bruce-Keller AJ, Gupta S, Parrino TE, Knight AG, Ebenezer PJ, Weidner AM, LeVine H, 3rd, Keller JN, and Markesbery WR.NOXactivity is increased in mild cognitive impairment. Antioxid Redox Signal 12: 1371-1382, 2010.
13. Carnesecchi S, Deffert C, Pagano A, Garrido-Urbani S, Metrailler-Ruchonnet I, Schappi M, Donati Y, Matthay MA, Krause KH, and Barazzone Argiroffo C. NADPH oxidase-1 plays a crucial role in hyperoxia-induced acute lung injury in mice. Am J Respir Crit Care Med 180: 972-981, 2009.
14. Casado A, Encarnacion Lopez-Fernandez M, Concepcion Casado M, and de La Torre R. Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias. Neurochem Res 33: 450-458, 2008.
15. Cheng G, Cao Z, Xu X, van Meir EG, and Lambeth JD. Homologs of gp91phox: Cloning and tissue expression of Nox3, Nox4, and Nox5. Gene 269: 131-140, 2001.
16. Choi BR, Lee SR, Han JS, Woo SK, Kim KM, Choi DH, Kwon KJ, Han SH, Shin CY, Lee J, Chung CS, Lee SR, and Kim HY. Synergistic memory impairment through the interaction of chronic cerebral hypoperfusion and amlyloid toxicity in a rat model. Stroke 42: 2595-2604, 2011.
17. Choi DH, Cristovao AC, Guhathakurta S, Lee J, Joh TH, Beal MF, and Kim YS. NADPH oxidase 1-mediated oxidative stress leads to dopamine neuron death in Parkinson's disease. Antioxid Redox Signal 16: 1033-1045, 2012.
18. Choi SH, Lee DY, Chung ES, Hong YB, Kim SU, and Jin BK. Inhibition of thrombin-induced microglial activation and NADPH oxidase by minocycline protects dopaminergic neurons in the substantia nigra in vivo. J Neurochem 95: 1755-1765, 2005.
19. Coyoy A, Valencia A, Guemez-Gamboa A, and Moran J. Role of NADPH oxidase in the apoptotic death of cultured cerebellar granule neurons. Free Radic Biol Med 45: 1056-1064, 2008.
20. Cristovao AC, Choi DH, Baltazar G, Beal MF, and Kim YS. The role of NADPH oxidase 1-derived reactive oxygen species in paraquat-mediated dopaminergic cell death. Antioxid Redox Signal 11: 2105-2118, 2009.
21. Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest 117: 868-870, 2007.
22. De Deken X, Wang D, Many MC, Costagliola S, Libert F, Vassart G, Dumont JE, and Miot F. Cloning of two human thyroid cDNAs encoding new members of the NADPH oxidase family. J Biol Chem 275: 23227-23233, 2000.
23. de la Torre JC. Vascular risk factor detection and control may preventAlzheimer's disease. AgeingResRev 9: 218-225, 2010.
24. Di Domenico F, Barone E, Mancuso C, Perluigi M, Cocciolo A, Mecocci P, Butterfield DA, and Coccia R. HO-1/BVR-a system analysis in plasma from probable Alzheimer's disease and mild cognitive impairment subjects: A potential biochemical marker for the prediction of the disease. J Alzheimers Dis 32: 277-289, 2012.
25. Dong YF, Kataoka K, Toyama K, Sueta D, Koibuchi N, Yamamoto E, Yata K, Tomimoto H, Ogawa H, and Kim-Mitsuyama S. Attenuation of brain damage and cognitive impairment by direct renin inhibition in mice with chronic cerebral hypoperfusion. Hypertension 58: 635-642, 2011.
26. Edens WA, Sharling L, Cheng G, Shapira R, Kinkade JM, Lee T, Edens HA, Tang X, Sullards C, Flaherty DB, Benian GM, and Lambeth JD. Tyrosine cross-linking of extracellular matrix is catalyzed by Duox, a multidomain oxidase/peroxidase with homology to the phagocyte oxidase subunit gp91phox. J Cell Biol 154: 879-891, 2001.
27. Erkinjuntti T, Roman G, Gauthier S, Feldman H, and Rockwood K. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 35: 1010-1017, 2004.
28. Famulari AL, Marschoff ER, Llesuy SF, Kohan S, Serra JA, Dominguez RO, Repetto M, Reides C, and Sacerdote de Lustig E. The antioxidant enzymatic blood profile in Alzheimer's and vascular diseases. Their association and a possible assay to differentiate demented subjects and controls. J Neurol Sci 141: 69-78, 1996.
29. Farkas E, Luiten PG, and Bari F. Permanent, bilateral common carotid artery occlusion in the rat: A model for chronic cerebral hypoperfusion-related neurodegenerative diseases. Brain Res Rev 54: 162-180, 2007.
30. Gackowski D, Rozalski R, Siomek A, Dziaman T, Nicpon K, Klimarczyk M, Araszkiewicz A, and Olinski R. Oxidative stress and oxidative DNA damage is characteristic for mixed Alzheimer disease/vascular dementia. J Neurol Sci 266: 57-62, 2008.
31. Harraz MM, Marden JJ, Zhou W, Zhang Y, Williams A, Sharov VS, Nelson K, Luo M, Paulson H, Schoneich C, and Engelhardt JF. SOD1 mutations disrupt redox-sensitive Rac regulation of NADPH oxidase in a familial ALS model. J Clin Invest 118: 659-670, 2008.
32. Jackman KA, Miller AA, Drummond GR, and Sobey CG. Importance of NOX1 for angiotensin II-induced cerebrovascular superoxide production and cortical infarct volume following ischemic stroke. Brain Res 1286: 215-220, 2009.
33. Jellinger KA. Morphologic diagnosis of "vascular dementia"-a critical update. J Neurol Sci 270: 1-12, 2008.
34. Ji HJ, Hu JF, Wang YH, Chen XY, Zhou R, and Chen NH. Osthole improves chronic cerebral hypoperfusion induced cognitive deficits and neuronal damage in hippocampus. Eur J Pharmacol 636: 96-101, 2010.
35. Jiwa NS, Garrard P, and Hainsworth AH. Experimental models of vascular dementia and vascular cognitive impairment: A systematic review. J Neurochem 115: 814-828, 2010.
36. Kahles T, Luedike P, Endres M, Galla HJ, Steinmetz H, Busse R, Neumann-Haefelin T, and Brandes RP. NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke. Stroke 38: 3000-3006, 2007.
37. Kauppinen TM, Higashi Y, Suh SW, Escartin C, Nagasawa K, and Swanson RA. Zinc triggers microglial activation. J Neurosci 28: 5827-5835, 2008.
38. Kim HJ, Lee JH, Kim SJ, Oh GS, Moon HD, Kwon KB, Park C, Park BH, Lee HK, Chung SY, Park R, and So HS. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J Neurosci 30: 3933-3946, 2010.
39. Kim MJ, Shin KS, Chung YB, Jung KW, Cha CI, and Shin DH. Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain. Brain Res 1040: 178-186, 2005.
40. Kim YS, Choi DH, Block ML, Lorenzl S, Yang L, Kim YJ, Sugama S, Cho BP, Hwang O, Browne SE, Kim SY, Hong JS, Beal MF, and Joh TH. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J 21: 179-187, 2007.
41. Kim YS, Morgan MJ, Choksi S, and Liu ZG. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol Cell 26: 675-687, 2007.
42. Kimura S, Zhang GX, Nishiyama A, Shokoji T, Yao L, Fan YY, Rahman M, Suzuki T, Maeta H, and Abe Y. Role of NAD(P)H oxidase-and mitochondria-derived reactive oxygen species in cardioprotection of ischemic reperfusion injury by angiotensin II. Hypertension 45: 860-866, 2005.
43. Kishida KT, Hoeffer CA, Hu D, Pao M, Holland SM, and Klann E. Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol Cell Biol 26: 5908-5920, 2006.
44. Kishida KT and Klann E. Sources and targets of reactive oxygen species in synaptic plasticity and memory. Antioxid Redox Signal 9: 233-244, 2007.
45. Kleinschnitz C, Grund H, Wingler K, Armitage ME, Jones E, Mittal M, Barit D, Schwarz T, Geis C, Kraft P, Barthel K, Schuhmann MK, Herrmann AM, Meuth SG, Stoll G, Meurer S, Schrewe A, Becker L, Gailus-Durner V, Fuchs H, Klopstock T, de Angelis MH, Jandeleit-Dahm K, Shah AM, Weissmann N, and Schmidt HH. Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration. PLoS Biol 8: Pii:e1000479, 2010.
46. Lin MS, Chiu MJ, Wu YW, Huang CC, Chao CC, Chen YH, Lin HJ, Li HY, Chen YF, Lin LC, Liu YB, Chao CL, Tseng WY, Chen MF, and Kao HL. Neurocognitive improvement after carotid artery stenting in patients with chronic internal carotid artery occlusion and cerebral ischemia. Stroke 42: 2850-2854, 2011.
47. Liu H and Zhang J. Cerebral hypoperfusion and cognitive impairment: The pathogenic role of vascular oxidative stress. Int J Neurosci 122: 494-499, 2012.
48. Mancuso C, Scapagini G, Curro D, Giuffrida Stella AM, De Marco C, Butterfield DA, and Calabrese V. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci 12: 1107-1123, 2007.
49. Miller AA, Drummond GR, and Sobey CG. Novel isoforms of NADPH-oxidase in cerebral vascular control. Pharmacol Ther 111: 928-948, 2006.
50. Mouravlev A, Dunning J, Young D, and During MJ. Somatic gene transfer of cAMP response element-binding protein attenuates memory impairment in aging rats. Proc Natl Acad Sci USA 103: 4705-4710, 2006.
51. Naritomi H. Experimental basis of multi-infarct dementia: Memory impairments in rodent models of ischemia. Alzheimer Dis Assoc Disord 5: 103-111, 1991.
52. Ni J, Ohta H, Matsumoto K, and Watanabe H. Progressive cognitive impairment following chronic cerebral hypoperfusion induced by permanent occlusion of bilateral carotid arteries in rats. Brain Res 653: 231-236, 1994.
53. Nikolova S, Lee YS, and Kim JA. Rac1-NADPH oxidaseregulated generation of reactive oxygen species mediates glutamate-induced apoptosis in SH-SY5Y human neuroblastoma cells. Free Radic Res 39: 1295-1304, 2005.
54. Noh KM and Koh JY. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. J Neurosci 20: RC111, 2000.
55. Pi Y, Zhang LL, Li BH, Guo L, Cao XJ, Gao CY, and Li JC. Inhibition of reactive oxygen species generation attenuates TLR4-mediated proinflammatory and proliferative phenotype of vascular smooth muscle cells. Lab Invest 93: 880-887, 2013.
56. Pimentel-Coelho PM, Michaud JP, and Rivest S. Effects of mild chronic cerebral hypoperfusion and early amyloid pathology on spatial learning and the cellular innate immune response in mice. Neurobiol Aging 34: 679-693, 2013.
57. Rajagopalan S, Kurz S, Munzel T, Tarpey M, Freeman BA, Griendling KK, and Harrison DG. Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J Clin Invest 97: 1916-1923, 1996.
58. Rodriguez-Lebron E, Denovan-Wright EM, Nash K, Lewin AS, and Mandel RJ. Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice. Mol Ther 12: 618-633, 2005.
59. Roman GC. Vascular dementia: Distinguishing characteristics, treatment, and prevention. J Am Geriatr Soc 51: S296-S304, 2003.
60. Rossi F and Zatti M. Biochemical aspects of phagocytosis in polymorphonuclear leucocytes. NADH and NADPH oxidation by the granules of resting and phagocytizing cells. Experientia 20: 21-23, 1964.
61. Schiavone S, Sorce S, Dubois-Dauphin M, Jaquet V, Colaianna M, Zotti M, Cuomo V, Trabace L, and Krause KH. Involvement of NOX2 in the development of behavioral and pathologic alterations in isolated rats. Biol Psychiatry 66: 384-392, 2009.
62. Selemidis S, Sobey CG, Wingler K, Schmidt HH, and Drummond GR. NADPH oxidases in the vasculature: Molecular features, roles in disease and pharmacological inhibition. Pharmacol Ther 120: 254-291, 2008.
63. Serrano F, Kolluri NS, Wientjes FB, Card JP, and Klann E. NADPH oxidase immunoreactivity in the mouse brain. Brain Res 988: 193-198, 2003.
64. Shi GX, Liu CZ, Wang LP, Guan LP, and Li SQ. Biomarkers of oxidative stress in vascular dementia patients. Can J Neurol Sci 39: 65-68, 2012.
65. Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, Fujita Y, Ohtani R, Ihara M, Takahashi R, and Tomimoto H. Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke 38: 2826-2832, 2007.
66. Sonta T, Inoguchi T, Tsubouchi H, Sekiguchi N, Kobayashi K, Matsumoto S, Utsumi H, and Nawata H. Evidence for contribution of vascular NAD(P)H oxidase to increased oxidative stress in animal models of diabetes and obesity. Free Radic Biol Med 37: 115-123, 2004.
67. Suh SW, Gum ET, Hamby AM, Chan PH, and Swanson RA. Hypoglycemic neuronal death is triggered by glucose reperfusion and activation of neuronal NADPH oxidase. J Clin Invest 117: 910-918, 2007.
68. Suh SW, Shin BS, Ma H, Van Hoecke M, Brennan AM, Yenari MA, and Swanson RA. Glucose and NADPH oxidase drive neuronal superoxide formation in stroke. Ann Neurol 64: 654-663, 2008.
69. Suh YA, Arnold RS, Lassegue B, Shi J, Xu X, Sorescu D, Chung AB, Griendling KK, and Lambeth JD. Cell transformation by the superoxide-generating oxidase Mox1. Nature 401: 79-82, 1999.
70. Tammariello SP, Quinn MT, and Estus S. NADPH oxidase contributes directly to oxidative stress and apoptosis in nerve growth factor-deprived sympathetic neurons. J Neurosci 20: RC53, 2000.
71. Tang XN, Cairns B, Cairns N, and Yenari MA. Apocynin improves outcome in experimental stroke with a narrow dose range. Neuroscience 154: 556-562, 2008.
72. Tejada-Simon MV, Serrano F, Villasana LE, Kanterewicz BI, Wu GY, Quinn MT, and Klann E. Synaptic localization of a functional NADPH oxidase in the mouse hippocampus. Mol Cell Neurosci 29: 97-106, 2005.
73. Ueyama T, Geiszt M, and Leto TL. Involvement of Rac1 in activation of multicomponent Nox1-and Nox3-based NADPH oxidases. Mol Cell Biol 26: 2160-2174, 2006.
74. Wang Q, Tompkins KD, Simonyi A, Korthuis RJ, Sun AY, and Sun GY. Apocynin protects against global cerebral ischemia-reperfusion-induced oxidative stress and injury in the gerbil hippocampus. Brain Res 1090: 182-189, 2006.
75. Wang T, Wang J, Yin C, Liu R, Zhang JH, and Qin X. Down-regulation of Nogo receptor promotes functional recovery by enhancing axonal connectivity after experimental stroke in rats. Brain Res 1360: 147-158, 2010.
76. Wilkinson BL and Landreth GE. The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease. J Neuroinflamm 3: 30, 2006.
77. Won SJ, Yoo BH, Kauppinen TM, Choi BY, Kim JH, Jang BG, Lee MW, Sohn M, Liu J, Swanson RA, and Suh SW. Recurrent/moderate hypoglycemia induces hippocampal dendritic injury, microglial activation, and cognitive impairment in diabetic rats. J Neuroinflamm 9: 182, 2012.